Pezzoli G - Search Results

1

COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy.

Fasano A, Cereda E, Barichella M, Cassani E, Ferri V, Zecchinelli AL, Pezzoli G. Fasano A, et al. Among authors: pezzoli g. Mov Disord. 2020 Jul;35(7):1089-1093. doi: 10.1002/mds.28176. Epub 2020 Jun 26. Mov Disord. 2020. PMID: 32484584 Free PMC article.

2

Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats.

Pezzoli G, Zecchinelli A, Ricciardi S, Burke RE, Fahn S, Scarlato G, Carenzi A. Pezzoli G, et al. Mov Disord. 1991;6(4):281-7. doi: 10.1002/mds.870060403. Mov Disord. 1991. PMID: 1684638

3

[Pergolide mesylate in the treatment of Parkinson's disease resistant to other treatments. First Italian experience].

Pezzoli G, Zecchinelli A, Mariani C, Reganati P, Scarlato G. Pezzoli G, et al. Clin Ter. 1991 Jan 15;136(1):39-45. Clin Ter. 1991. PMID: 1826872 Clinical Trial. Italian.

4

Adrenal medulla autograft in 3 parkinsonian patients: results using two different approaches.

Pezzoli G, Motti E, Zecchinelli A, Ferrante C, Silani V, Falini A, Pizzuti A, Mulazzi D, Baratta P, Vegeto A, et al. Pezzoli G, et al. Prog Brain Res. 1990;82:677-82. doi: 10.1016/s0079-6123(08)62659-x. Prog Brain Res. 1990. PMID: 2290970 No abstract available.

5

[An open study of a new formulation of the levodopa and benserazide combination in the treatment of fluctuations of motor performance in patients with Parkinson's disease].

Pezzoli G, Tesei S, Cossutta E, Ferrante C, Zecchinelli A, Scarlato G. Pezzoli G, et al. Clin Ter. 1988 Apr 30;125(2):115-20. Clin Ter. 1988. PMID: 2973932 Italian. No abstract available.

6

Madopar HBS in fluctuating parkinsonian patients: two-year treatment.

Pezzoli G, Tesei S, Ferrante C, Cossutta E, Zecchinelli A, Scarlato G. Pezzoli G, et al. Mov Disord. 1988;3(1):37-45. doi: 10.1002/mds.870030106. Mov Disord. 1988. PMID: 3050471 Clinical Trial.

7

Primary cultures of human caudate nucleus.

Silani V, Pezzoli G, Motti E, Falini A, Pizzuti A, Ferrante C, Zecchinelli A, Marossero F, Scarlato G. Silani V, et al. Among authors: pezzoli g. Appl Neurophysiol. 1988;51(1):10-20. doi: 10.1159/000099379. Appl Neurophysiol. 1988. PMID: 3389788

8

n-Hexane-induced parkinsonism: pathogenetic hypotheses.

Pezzoli G, Antonini A, Barbieri S, Canesi M, Perbellini L, Zecchinelli A, Mariani CB, Bonetti A, Leenders KL. Pezzoli G, et al. Mov Disord. 1995 May;10(3):279-82. doi: 10.1002/mds.870100308. Mov Disord. 1995. PMID: 7651443

9

Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.

Pezzoli G, Martignoni E, Pacchetti C, Angeleri VA, Lamberti P, Muratorio A, Bonuccelli U, De Mari M, Foschi N, Cossutta E, et al. Pezzoli G, et al. Mov Disord. 1994 Jul;9(4):431-6. doi: 10.1002/mds.870090409. Mov Disord. 1994. PMID: 7969210 Clinical Trial.

10

Clinical and pathological features in hydrocarbon-induced parkinsonism.

Pezzoli G, Strada O, Silani V, Zecchinelli A, Perbellini L, Javoy-Agid F, Ghidoni P, Motti ED, Masini T, Scarlato G, Agid Y, Hirsch EC. Pezzoli G, et al. Ann Neurol. 1996 Dec;40(6):922-5. doi: 10.1002/ana.410400616. Ann Neurol. 1996. PMID: 9007099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

366 results

Search Page